ArticleCommunications biology2025
A large-scale benchmark for network inference from single-cell perturbation data.
Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Multi-omics-driven precision medicine.iMeta · 2026Review
- Causal graph neural networks for healthcare.Nature biomedical engineering · 2026Review
- Multiscale systems modelling of communication networks in brain metastasis.Experimental & molecular medicine · 2026Review
- From Prediction to Creation: Generative Plant Design.Plants (Basel, Switzerland) · 2026Review
- DataXflowGen for GenAI-driven model generation.Scientific reports · 2026Article
- Differential gene regulatory network analysis reveals transcriptional disruption in opioid.NAR genomics and bioinformatics · 2026Article
- Network methods for diagonal integration of unpaired single-cell multiomics data: a review.Bioinformatics (Oxford, England) · 2026Review
- Interpretation, extrapolation and perturbation of single cells.Nature reviews. Genetics · 2026Review
- PSGRN: Gene regulatory network inference from single-cell perturbational data through self-training with synthetic gold standards.Science advances · 2026Article
- Toward trustworthy virtual cells: a roadmap for perturbation-resolved, context-aware, and experimentally validated cell models.Frontiers in cell and developmental biology · 2026Review
- Temporal network analysis in systems biology: concepts, inference, and validation.Frontiers in bioinformatics · 2026Review
- In silico biological discovery with large perturbation models.Nature computational science · 2025Article
- Gene regulatory network structure informs the distribution of perturbation effects.PLoS computational biology · 2025Article
- GPO-VAE: modeling explainable gene perturbation responses utilizing GRN-aligned parameter optimization.Bioinformatics (Oxford, England) · 2025Article
- Perspective on recent developments and challenges in regulatory and systems genomics.Bioinformatics advances · 2025Review
- Molecular causality in the advent of foundation models.Molecular systems biology · 2024Review
- Stochastic Modeling of Biophysical Responses to Perturbation.bioRxiv : the preprint server for biology · 2024Article
- AI approaches for the discovery and validation of drug targets.Cambridge prisms. Precision medicine · 2024Review
- Approaches for Benchmarking Single-Cell Gene Regulatory Network Methods.Bioinformatics and biology insights · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mapping biological mechanisms in cellular systems is a fundamental step in early-stage drug discovery that serves to generate hypotheses on what disease-relevant molecular targets may effectively be modulated by pharmacological interventions. With the advent of high-throughput methods for measuring single-cell gene expression under genetic perturbations, we now have effective means for generating evidence for causal gene-gene interactions at scale. However, evaluating the performance of network inference methods in real-world environments is challenging due to the lack of ground-truth knowledge. Moreover, traditional evaluations conducted on synthetic datasets do not reflect the performance in real-world systems. We thus introduce CausalBench, a benchmark suite revolutionizing network inference evaluation with real-world, large-scale single-cell perturbation data. CausalBench, distinct from existing benchmarks, offers biologically-motivated metrics and distribution-based interventional measures, providing a more realistic evaluation of network inference methods. An initial systematic evaluation of state-of-the-art causal inference methods using our CausalBench suite highlights how poor scalability of existing methods limits performance. Moreover, methods that use interventional information do not outperform those that only use observational data, contrary to what is observed on synthetic benchmarks. CausalBench subsequently enables the development of numerous promising methods through a community challenge, thus demonstrating its potential as a transformative tool in the field of computational biology, bridging the gap between theoretical innovation and practical application in drug discovery and disease understanding. Thus, CausalBench opens new avenues for method developers in causal network inference research, and provides to practitioners a principled and reliable way to track progress in network methods for real-world interventional data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.